Andrew Vernon

1.7k total citations
12 papers, 1.2k citations indexed

About

Andrew Vernon is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Andrew Vernon has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Andrew Vernon's work include Tuberculosis Research and Epidemiology (9 papers), Cancer therapeutics and mechanisms (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Andrew Vernon is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Cancer therapeutics and mechanisms (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Andrew Vernon collaborates with scholars based in United States, France and Canada. Andrew Vernon's co-authors include Awal Khan, Debra Benator, Lorna Bozeman, William J. Burman, Richard E. Chaisson, C. Robert Horsburgh, Richard O’Brien, J Grosset, Sandeep Tyagi and Tetsuyuki Yoshimatsu and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Andrew Vernon

12 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Vernon United States 11 1.1k 859 501 147 100 12 1.2k
Awal Khan United States 12 1.1k 1.0× 860 1.0× 478 1.0× 91 0.6× 99 1.0× 20 1.2k
Eric Nuermberger United States 19 1.2k 1.1× 831 1.0× 401 0.8× 308 2.1× 198 2.0× 21 1.4k
P Chaulet Algeria 12 950 0.9× 755 0.9× 444 0.9× 136 0.9× 29 0.3× 49 1.2k
P C Hopewell United States 18 976 0.9× 1.0k 1.2× 398 0.8× 85 0.6× 62 0.6× 25 1.3k
Thuli Mthiyane South Africa 16 1.2k 1.1× 913 1.1× 428 0.9× 214 1.5× 142 1.4× 28 1.5k
Gregory Symons South Africa 9 694 0.7× 523 0.6× 276 0.6× 164 1.1× 59 0.6× 15 882
Sundari Mase United States 17 982 0.9× 751 0.9× 437 0.9× 110 0.7× 38 0.4× 41 1.1k
Hee Jin Kim South Korea 19 1.1k 1.1× 892 1.0× 571 1.1× 94 0.6× 25 0.3× 76 1.4k
Maia Kipiani Georgia 18 690 0.6× 472 0.5× 270 0.5× 144 1.0× 70 0.7× 44 924
Vaira Leimane United States 19 2.2k 2.1× 1.8k 2.1× 886 1.8× 227 1.5× 73 0.7× 30 2.4k

Countries citing papers authored by Andrew Vernon

Since Specialization
Citations

This map shows the geographic impact of Andrew Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Vernon more than expected).

Fields of papers citing papers by Andrew Vernon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Vernon. The network helps show where Andrew Vernon may publish in the future.

Co-authorship network of co-authors of Andrew Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Vernon. A scholar is included among the top collaborators of Andrew Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Vernon. Andrew Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vernon, Andrew. (2013). Treatment of Latent Tuberculosis Infection. Seminars in Respiratory and Critical Care Medicine. 34(1). 67–86. 24 indexed citations
2.
Tedla, Zegabriel, Samba Nyirenda, Crandall E. Peeler, et al.. (2010). Isoniazid-associated Hepatitis and Antiretroviral Drugs during Tuberculosis Prophylaxis in HIV-infected Adults in Botswana. American Journal of Respiratory and Critical Care Medicine. 182(2). 278–285. 37 indexed citations
3.
Hamilton, Carol, Jason E. Stout, Philip C. Goodman, et al.. (2008). The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse.. PubMed. 12(9). 1059–64. 37 indexed citations
4.
Khan, Awal, Timothy R. Sterling, Randall Reves, Andrew Vernon, & C. Robert Horsburgh. (2006). Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial. American Journal of Respiratory and Critical Care Medicine. 174(3). 344–348. 137 indexed citations
5.
Nuermberger, Eric L., Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.. (2003). Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 169(3). 421–426. 242 indexed citations
6.
7.
Johnson, John L., Alphonse Okwera, David L. Hom, et al.. (2001). Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS. 15(16). 2137–2147. 118 indexed citations
8.
Lounis, Nacer, C. Truffot-Pernot, Baohong Ji, et al.. (2001). Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in Mice. Antimicrobial Agents and Chemotherapy. 45(12). 3482–3486. 61 indexed citations
9.
Daniel, Nathalie, Nacer Lounis, Baohong Ji, et al.. (2000). Antituberculosis Activity of Once-weekly Rifapentine-containing Regimens in Mice: Long-term Effectiveness with 6- and 8-Month Treatment Regimens. American Journal of Respiratory and Critical Care Medicine. 161(5). 1572–1577. 26 indexed citations
10.
Vernon, Andrew, William J. Burman, Debra Benator, Awal Khan, & Lorna Bozeman. (1999). Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. The Lancet. 353(9167). 1843–1847. 227 indexed citations
11.
Vernon, Andrew, Leslie R. Sheeler, Charles V. Biscotti, & James K. Stoller. (1992). Pleural Effusion Resulting from Metastatic Papillary Carcinoma of the Thyroid. CHEST Journal. 101(5). 1448–1450. 20 indexed citations
12.
Parsons, V., V. M. Dalley, Diana Brinkley, Christine Davies, & Andrew Vernon. (1974). THE EFFECTS OF CALCITONIN ON THE METABOLIC DISTURBANCES SURROUNDING WIDESPREAD BONY METASTASES. European Journal of Endocrinology. 76(2). 286–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Awal Khan Breakdown of academic impact, for papers by Eric Nuermberger Breakdown of academic impact, for papers by P Chaulet Breakdown of academic impact, for papers by P C Hopewell Breakdown of academic impact, for papers by Thuli Mthiyane Breakdown of academic impact, for papers by Gregory Symons Breakdown of academic impact, for papers by Sundari Mase Breakdown of academic impact, for papers by Hee Jin Kim Breakdown of academic impact, for papers by Maia Kipiani Breakdown of academic impact, for papers by Vaira Leimane
Rankless by CCL
2026